Abstract:INTRODUCTION: We have recently shown that neutrophilic myeloid-derived suppressor cells (MDSC) are the dominant source of TNF in the pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME). Moreover, neutrophil-derived TNF amplifies stromal fibrosis and immune tolerance via transmembraneTNF-TNFR2 interactions to promote therapeutic resistance in PDAC. Here, we develop a novel tumor-bearing murine model with efficient neutrophil lineage-restricted inactivation of Tnf to mechanistically dissect the impact of neutrophil-intrinsic TNF on stromal and T-cell dysfunction in PDAC. METHODS: We generated a neutrophil-lineage restricted MRP8Cre/+Tnfflox/flox model (Neu-TnfKO) by crossing Tnfflox/flox mice with mice bearing Cre-recombinase under control of MRP8 neutrophilic promoter, and confirmed >98% Tnf reduction in circulating neutrophils. Orthotopically implanted KPC tumors in Neu-TnfKO vs. littermates (MRP8Cre+/−Tnf+/+ or MRP8Cre-/−Tnffl/fl) were subjected to single-cell RNAseq (scRNAseq), flow cytometric immunophenotyping, and tissue histology. RESULTS: Compared with littermate controls, primary tumor weights and frequency of liver metastasis were significantly reduced in Neu-TnfKO mice. ScRNAseq in CD45− fraction of d21 tumors in Neu-TnfKO vs. control mice revealed downregulation of myofibroblastic features (i.e., Ccn2, Tgfb1), hypoxia signaling, and metabolic dysregulation in CAF single-cell transcriptomes. Tissue histology in Neu-TnfKO tumors revealed striking attenuation in fibrotic collagen deposition, and myofibril organization. Moreover, Lrrc15—implicated as a central regulator of CAF-driven immunotherapy resistance—was downregulated in Neu-TnfKO CAFs. This remodeling of stromal fibrosis manifested in increased trafficking of T-cells into Neu-TnfKO vs. littermate tumors via immunostaining and flow cytometry. ScRNAseq in CD45+ fractions of Neu-TnfKO mice corroborated enrichment in effector/helper T-cell and attenuation of MDSC and macrophage populations. In investigating if neutrophil-restricted Tnf silencing invokes reprogramming of T-cell single-cell transcriptomes, we observed global skewness towards effector vs exhausted programming in Neu-TnfKO tumors; enrichment of pathways related to ribosomal activation, interferon signaling, and negative regulation of T-cell apoptosis; and overexpression of multiple effector function genes—e.g., Adgre5, Cam1kd, Dgka—together indicating functional T-cell activation. Flow cytometry validated this activated CD8+ T-cell phenotype in Neu-TnfKO tumor-infiltrating by highlighting increased antigen-experienced (PD1+CD39neg) and short-lived effector populations (P<0.0001), and also revealed reduction in terminally exhausted (CD69+Ly108− in PD1hi) CD8+ T-cell subsets (P=0.028). CONCLUSIONS: Conditional silencing of neutrophilic-restricted TNF reprograms the immunotherapy-restrictive CAF and T-cell landscapes in the PDAC TME. Compartment-specific inhibition of TNF may be a provocative strategy to overcome immunotherapy resistance in PDAC. Citation Format: Anna Bianchi, Haleh Amirian, Iago De Castro Silva, Ifeanyichukwu Ogobuiro, Karthik Rajkumar, Andrew Mark Adams, Vanessa Garrido, Samara Singh, Siddharth Mehra, Christine Rafie, Nagarj Nagathihalli, Erietta Stelekati, Nipun Merchant, Jashodeep Datta. Neutrophil-intrinsic tumor necrosis factor (TNF) is a novel driver of T-cell and cancer-associated fibroblast (CAF) dysfunction in pancreatic cancer [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Pancreatic Cancer; 2023 Sep 27-30; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(2 Suppl) nr PR16.

Abstract A086: TFEB protects pancreatic cancer cells against nucleolar stress

Gemcitabine promotes autophagy and lysosomal function through ERK- and TFEB-dependent mechanisms

Abstract B090: Targeting the unfolded protein response enhances sensitivity to chemotherapy

Abstract 3274: Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer

Abstract 6349A: Mechanical stress activates autophagy to induce drug resistance in pancreatic cancer cells

Abstract B054: Investigating ER stress responses in pancreatic ductal adenocarcinoma under lipid imbalance

The Cytoprotective Role Of Gemcitabine-Induced Autophagy Associated With Apoptosis Inhibition In Triple-Negative Mda-Mb-231 Breast Cancer Cells

Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes

Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma

Abstract C091: Harnessing proteostatic vulnerabilities in pancreatic cancer

Targeting Mitochondrial Transcription Factor A Sensitizes Pancreatic Cancer Cell to Gemcitabine.

Abstract PR023: Targeting gemcitabine resistance in pancreatic cancer

TFEB-driven Autophagy Potentiates TGF-β Induced Migration in Pancreatic Cancer Cells.

TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3

OXCT1 Enhances Gemcitabine Resistance Through NF-B Pathway in Pancreatic Ductal Adenocarcinoma

Abstract B039: Elucidating the tumor-driven mechanisms of resistance to immunotherapies in pancreatic cancer through in vivo CRISPR/Cas9 knockout screening

Abstract A058: Primary cancer-associated fibroblasts alter tumor organoid chemosensitivity through epigenetic regulation

NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response

TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer

Gemcitabine Enhances Cell Invasion Via Activating HAb18G/CD147-EGFR-pSTAT3 Signaling

Abstract PR16: Neutrophil-intrinsic tumor necrosis factor (TNF) is a novel driver of T-cell and cancer-associated fibroblast (CAF) dysfunction in pancreatic cancer